Clinical Trial Update: A Clinical Study of GO306 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This document reports an ongoing Phase 1 study of GO306 in patients with advanced solid tumors. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• GO306

Snippet

Sponsor: GeneSail Biotech (Shanghai) Co., Ltd. | Conditions: Solid Tumor Malignancies | Phase 1 | Status: RECRUITING